GC Corp.

₩9,470As of Sun 8 Nov 2026, 12:00 UTC
KRX:005250Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (6.66%)
Div yield 3.17%
ROE (8.38%)
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM (38.62%)
Mkt cap ₩430.3B
ROIC 0.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩10,910
15.20%
(46.88%)
Hold 0|8|1|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
133.80
147.29
143.96
154.85
45.53%
43.74%
29.75%
27.95%
Revenue₩B
23.50
24.45
25.45
26.96
9.49%
8.13%
9.73%
11.97%
Peers (US$317.3M)
Cap (US$)
PE
304.7M
28.60x
Capital
TTM
5Y
10Y
Leveragex
0.535
(0.105)
(0.102)
EBIT/Intx
0.260
0.809
0.706
Own earn%
157.24
(205.10)
(171.71)
Sh yield%
58.69
46.88
42.07
Owners
Insiders/Inst%
11.92
78.17
Short interest%
1.66
SBC / revenue%
4.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
22–32
$1 testx
—
Incr. ROIC%
6